Case Western Reserve University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Case Western Reserve University sits in the top decile of US sponsors by registered trial count (#198 of 15,742 sponsors by registered trial count).
Case Western Reserve University: 141 sponsored US clinical trials, 23 recruiting.
Case Western Reserve University sponsors 141 registered US clinical trials on ClinicalTrials.gov, 23 of them currently recruiting, and 100 completed. 6 of these trials are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Bipolar Disorder, with 6 trials.
Top-decile sponsor footprint
Case Western Reserve University ranks in the top decile of sponsors by registered trial count (#198 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
100 of 103 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.1%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
141 total, page 1 of 3
Humidity Asthma Interventions for Low Socioeconomic Status Children
NCT07453667
Effect of Arestin-Enhanced SRP on Periodontal and Glycemic Outcomes in Diabetics
NCT07298057
Youth Empowerment and Safety Intervention
NCT07214233
Development of Optimal Sensory Feedback Strategies to Maximize Function After Tetraplegia
NCT07225582
LT Comparative Effectiveness of 2 Caries Treatments
NCT07213661
Nourishing Tomorrow: Role of Medically Tailored Groceries in Addressing Food Insecurity During Pregnancy
NCT06965530
Preventing Athlete Under-fueling Through Nutrition.
NCT07136038
Positive Processes and Transition to Health - Single-Session (PATH-SS)
NCT06900712
Nourish Clinical Trial
NCT06947954
Developing Resilience and Anxiety Management Through the Arts
NCT07033052
Oral Health Intervention in Adult Primary Care
NCT06555029
Learning Skills Together Family Caregiver Complex Intervention
NCT05846984
Positive Processes and Transition to Health (PATH)
NCT06093906
Clean Hands Accessible and Manageable for Patients (CHAMPs)
NCT05866393
Changes in Microbial Status From Dentate, Edentulous and After Dental Implant Placement
NCT06149585
Comparison of Two Methods of Covering a Single Lower Front Tooth With Receded Gums
NCT06037161
Immediate Versus Delayed Loading of Maxillary Overdenture Implants
NCT06038487
The Effect of Womb Recordings on Maturation of Respiratory Control in Preterm Infants
NCT05298748
Nourishing Beginnings: Addressing Food Insecurity During Pregnancy
NCT05341960
Optimization of NIBS for Treatment of Addiction
NCT04379115
OPtimizing Technology to Improve Medication Adherence and BP Control (OPTIMA-BP)
NCT05293756
Evaluation of an Advanced Lower Extremity Neuroprostheses
NCT00623389
Genetic Determinants of Barrett's Esophagus and Esophageal Adenocarcinoma
NCT00288119
Improving Sleep Health Outcomes for Family Caregivers
NCT07513246
The Impact of Technology in Obstructive Sleep Apnea Myofunctional Therapy
NCT06905951
Diabetes Inspired Culinary Education (DICE): Culinary Medicine Intervention for At-Risk Youth With Type 1 Diabetes
NCT07084805
Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Adults With an Opioid Use Disorder (EXPO; R33 Phase)
NCT05688410
Effectiveness RCT of Customized Adherence Enhancement
NCT04622150
Using mHealth to Improve Adherence and Reduce Blood Pressure in Individuals With Hypertension and Mood Disorders
NCT04675593
Enhancing Exercise and Psychotherapy to Treat Pain and Addiction in Opioid Use Disorders ("EXPO" Pilot Trial)
NCT04736550
Optimization of NIBS for Diabetic Neuropathy Neuropathic Pain
NCT03625752
Effects of Semaglutide in HIV-Associated Lipohypertrophy
NCT04019197
REstoring Flow by REvascularization With Submaximal Angioplasty in Hemodynamic IntraCranial Atherosclerotic Stenosis
NCT03729817
REFRAME: an Emotion Regulation Intervention to Improve Psychological Outcomes in Surrogate Decision-Makers of the Critically Ill
NCT07630844
Supporting Just-In-Time Consent for Prenatal Screening: The INFORM Study
NCT07557303
Knowledge and Interpersonal Skills to Develop Enhanced Relationships (KINDER)
NCT07216950
Self-Monitoring OCT
NCT07584798
REACH Study (Recovery Environments: Assessing Cognitive & Brain Health in Community Mental Health)
NCT07006935
3D Modalities for Medical Student Education of Congenital Heart Disease
NCT07295730
Increasing Men's Engagement in Preventive Healthcare Through an Enhanced Cocoon Vaccination Strategy
NCT06437834
Effect of Grapes in Inflammatory Bowel Disease
NCT05972694
Exparel Versus Bupivacaine in Post-operative Pain Control
NCT06547255
Nutrition for Health and Performance in Female Collegiate Soccer Players
NCT06581237
Nourish Pilot & CoDesign Study
NCT06398197
Texting to Promote Breastfeeding (TOPS)
NCT06375655
CONFIDENCE-AI Financial Education for Caregivers (CONFIDENCE-AI)
NCT06134180
Evaluating Sleep Quality With Emerging Technologies
NCT06900530
Knowledge and Interpersonal Skills to Develop Exemplary Relationships (KINDER): Pilot Study
NCT05783102
CONFIDENCE Financial Education for Caregivers
NCT05292248
Self-Management in Young Adults With Type 1 Diabetes
NCT04975230
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 4 |
| Phase 3 | 2 |
| Phase 4 | 4 |
Therapeutic Areas
What is open in the Case Western Reserve University pipeline
23 recruiting of 141 indexed (16% open); 100 completed (71%).
Phase mix: 6 late (III/IV) vs 10 early (I/II) (early-phase heavy).
Top condition: Bipolar Disorder (6 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Case Western Reserve University: open-pipeline peers nationwide
Peers matched on 141 registered trials and 16% open enrollment, not the therapeutic-area sidebar.
Case Western Reserve University sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 141 trials (± recruiting share)
- Eastern Cooperative Oncology Group · 141 trials · 3% recruiting
- Purdue University · 141 trials · 10% recruiting
- Johnson & Johnson Vision Care · 142 trials · 1% recruiting
- Mclean Hospital · 140 trials · 19% recruiting
Sponsors near 16% open enrollment (± trial volume)
- Drexel University · 16% recruiting · 92 trials
- H. Lee Moffitt Cancer Center and Research Institute · 16% recruiting · 502 trials
- Atlantic Health System · 16% recruiting · 43 trials
- BioMarin Pharmaceutical · 16% recruiting · 80 trials
Related
What to do with this Case Western Reserve University page
141 registered trials is a research-attention snapshot, not an endorsement of Case Western Reserve University or any single study.
- 23 of Case Western Reserve University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Bipolar Disorder is the condition Case Western Reserve University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Bipolar Disorder trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Case Western Reserve University pipeline card: 141 registered trials from official public datasets.Report a data error.